Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
DEA Greven, ES Cohen, DM Gerlag, J Campbell, J Woods, N Davis, A van Nieuwenhuijze, A Lewis, S Heasmen, M McCourt, D Corkill, A Dodd, J Elvin, G Statache, IP Wicks, IK Anderson, A Nash, MA Sleeman, PP Tak
Annals of the Rheumatic Diseases | BMJ PUBLISHING GROUP | Published : 2015
This work was partly funded by MedImmune; a wholly owned subsidiary of Astrazeneca. This work was also partly funded by CSL Ltd, Australia.